Search results
5 cze 2024 · Pulmonary and mediastinal involvement of sarcoidosis is extremely common, seen in over 90% of patients with sarcoidosis. Radiographic features are variable depending on the stage of the disease. For a general discussion, please refer to the parent article: sarcoidosis. Epidemiology. Pulmonary manifestations are present in ~ 90% of patients.
Sarcoidosis is a systemic inflammatory granulomatous disease mainly affecting the lungs and thoracic lymph nodes. In a previous article in this journal, we reviewed emerging aspects of diagnosis and monitoring of the disease. This narrative paper aims to review and update sarcoidosis management.
Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative causes of granulomatous disease.
Pulmonary sarcoidosis causes inflammation and tiny lumps called granulomas in the lungs. Many people with this condition get well on their own or feel better with short-term treatment. If you have trouble breathing, talk to a healthcare provider for diagnosis and treatment options.
This Review summarizes the epidemiology, histopathology, diagnosis, and treatment of pulmonary manifestations of sarcoidosis.
25 cze 2023 · Sarcoidosis is a multisystem disorder of unknown etiology that mostly affects young adults worldwide and presents with noncaseating granulomas in various organs. Characteristically, it presents with bilateral hilar lymphadenopathy and reticular opacities in the lungs.
This British Thoracic Society (BTS) Clinical Statement addresses the diagnosis, evaluation and management of pulmonary sarcoidosis, with each section summarised with key clinical practice points.
